EARNINGS PER SHARE

The following tables show the computation of basic and diluted loss per common share for each period presented (in thousands, except per share amounts):



	Three Months Ended						Nine Months Ended
	October 28, 2017			October 29, 2016			October 28, 2017			October 29, 2016
Basic:
Net loss	$	(17,722	)	$	(15,634	)	$	(42,967	)	$	(31,053	)
Less: Allocation of earnings to participating securities	(66		)	—			(268		)	—
Net loss allocated to common shares	(17,788		)	(15,634		)	(43,235		)	(31,053		)

Basic weighted average shares outstanding	27,602			27,155			27,468			27,066
Basic loss per share	$	(0.64	)	$	(0.58	)	$	(1.57	)	$	(1.15	)

	Three Months Ended						Nine Months Ended
	October 28, 2017			October 29, 2016			October 28, 2017			October 29, 2016
Diluted:
Net loss	$	(17,722	)	$	(15,634	)	$	(42,967	)	$	(31,053	)
Less: Allocation of earnings to participating securities	(66		)	—			(268		)	—
Net loss allocated to common shares	(17,788		)	(15,634		)	(43,235		)	(31,053		)

Basic weighted average shares outstanding	27,602			27,155			27,468			27,066
Add: Dilutive effect of stock awards	—			—			—			—
Diluted weighted average shares outstanding	27,602			27,155			27,468			27,066
Diluted loss per share	$	(0.64	)	$	(0.58	)	$	(1.57	)	$	(1.15	)

The number of shares attributable to SARs and non-vested stock grants that would have been considered dilutive securities, but were excluded from the calculation of diluted loss per common share because the effect was anti-dilutive were as follows (in thousands):



	Three Months Ended		Nine Months Ended
	October 28, 2017	October 29, 2016	October 28, 2017	October 29, 2016
Number of anti-dilutive shares due to net loss for the period	—	20	—	42
Number of anti-dilutive SARs due to exercise price greater than average market price of our common stock	113	187	129	198